Spherical Aberration and Contrast Sensitivity Function in Eyes Implanted With Spherical and Aspheric Intraocular Lenses: A Clinical Trial

This study has been completed.
Information provided by:
Shahid Beheshti Medical University
ClinicalTrials.gov Identifier:
First received: December 8, 2009
Last updated: NA
Last verified: September 2006
History: No changes posted
Aspheric intraocular lenses can effectively reduce higher-order aberrations and improve contrast sensitivity function after cataract surgery.

Condition Intervention Phase
Device: Intraocular lens
Phase 4

Study Type: Interventional

Resource links provided by NLM:

Further study details as provided by Shahid Beheshti Medical University:

Arms Assigned Interventions
Sham Comparator: Sensar IOL Device: Intraocular lens
Active Comparator: Tecnis IOL Device: Intraocular lens
Active Comparator: AcrySof IQ Device: Intraocular lens


Ages Eligible for Study:   55 Years to 75 Years
Genders Eligible for Study:   Both

Inclusion Criteria:

  • Senile cataract

Exclusion Criteria:

  • Glaucoma, corneal opacity, retinal abnormality, previous history
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01028872

Iran, Islamic Republic of
Labbafinejad Medical Center
Tehran, Iran, Islamic Republic of, 16666
Sponsors and Collaborators
Shahid Beheshti Medical University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT01028872     History of Changes
Other Study ID Numbers: 8547 
Study First Received: December 8, 2009
Last Updated: December 8, 2009
Health Authority: Iran: Ethics Committee

Keywords provided by Shahid Beheshti Medical University:
higher-order aberrations, contrast sensitivity

ClinicalTrials.gov processed this record on February 11, 2016